| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |